Abstract Purpose Pituitary dysfunction is reported to be a common complication following aneurysmal subarachnoid hemor rhage (aSAH). The aim of this meta-analysis is to analyze the literature on clinical prevalence, risk factors and out come impact of pituitary dysfunction after aSAH, and to assess the possible need for pituitary screening in aSAH patients. Methods We performed a systematic review with meta analysis based on a comprehensive search of four databases (PubMed/MEDLINE, ISI/Web of Science, Scopus and Google Scholar). Results A total of 20 papers met criteria for inclusion. The prevalence of pituitary dysfunction in the acute phase (within the first 6 months after aSAH) was 49.30 % (95 % CI 41.6–56.9), decreasing in the chronic phase (after 6 months from aSAH) to 25.6 % (95 % CI 18.0–35.1).

Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis / Robba, C; Bacigaluppi, S; Bragazzi, N; Lavinio, A; Gurnell, M; Bilotta, F; Menon, Dk. - In: PITUITARY. - ISSN 1386-341X. - 19:(2016), pp. 522-535.

Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis

Bilotta F;
2016

Abstract

Abstract Purpose Pituitary dysfunction is reported to be a common complication following aneurysmal subarachnoid hemor rhage (aSAH). The aim of this meta-analysis is to analyze the literature on clinical prevalence, risk factors and out come impact of pituitary dysfunction after aSAH, and to assess the possible need for pituitary screening in aSAH patients. Methods We performed a systematic review with meta analysis based on a comprehensive search of four databases (PubMed/MEDLINE, ISI/Web of Science, Scopus and Google Scholar). Results A total of 20 papers met criteria for inclusion. The prevalence of pituitary dysfunction in the acute phase (within the first 6 months after aSAH) was 49.30 % (95 % CI 41.6–56.9), decreasing in the chronic phase (after 6 months from aSAH) to 25.6 % (95 % CI 18.0–35.1).
2016
impact of pituitary dysfunction; aneurysmal subarachnoid hemorrhage; pituitary
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis / Robba, C; Bacigaluppi, S; Bragazzi, N; Lavinio, A; Gurnell, M; Bilotta, F; Menon, Dk. - In: PITUITARY. - ISSN 1386-341X. - 19:(2016), pp. 522-535.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1656891
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 15
social impact